{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T08:16:03Z","timestamp":1787991363782,"version":"build-2784847793"},"reference-count":12,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,21]]},"abstract":"<jats:title>Vignette<\/jats:title>\n                  <jats:p>A 49-year-old female with a history of chronic hypocalcemia had serum calcium concentrations that ranged between 6.4 and 8.5 mg\/dL (nl, 8.6-10.3 mg\/dL) with inappropriately low to low-normal parathyroid hormone (PTH) concentrations. She did not report symptoms of hypocalcemia. A thyroid nodule was discovered, and the patient underwent total thyroidectomy for papillary thyroid cancer. Parathyroid autotransplantation was not performed since parathyroid glands were not identified during the surgery. After total thyroidectomy, the patient developed a more severe symptomatic, refractory hypocalcemia with undetectable PTH concentrations. Postoperative pathologic examination identified a single hypercellular parathyroid gland. Despite medical treatment, including frequent and regular calcium gluconate infusions, serum calcium concentrations remained persistently low. A genetic evaluation identified a pathogenic GNA11 variant (c.178C&amp;gt;T, p.Arg60Cys), consistent with autosomal dominant hypocalcemia type 2 (ADH2). This case expands the understanding of ADH2 and raises important questions about optimal treatment strategies in patients with coexisting genetic and postsurgical hypoparathyroidism.<\/jats:p>","DOI":"10.1093\/jbmr\/zjag043","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T12:44:59Z","timestamp":1772023499000},"page":"934-939","source":"Crossref","is-referenced-by-count":0,"title":["Refractory hypocalcemia from combined autosomal dominant hypocalcemia type 2 and postsurgical hypoparathyroidism"],"prefix":"10.1093","volume":"41","author":[{"given":"Melda","family":"Sonmez Ince","sequence":"first","affiliation":[{"name":"Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan , Ann Arbor, MI \u00a0","place":["48106, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0151-804X","authenticated-orcid":false,"given":"Nazanene H","family":"Esfandiari","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan , Ann Arbor, MI 48106 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2975-5170","authenticated-orcid":false,"given":"Fadil M","family":"Hannan","sequence":"additional","affiliation":[{"name":"Nuffield Department of Women\u2019s and Reproductive Health, University of Oxford , Oxford ,","place":["OX3 9DU, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2536-732X","authenticated-orcid":false,"given":"Mehboob A","family":"Hussain","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan , Ann Arbor, MI 48106 ,","place":["United States"]},{"name":"Division of Endocrinology, Department of Medicine, University of California , Irvine, CA 92697 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0641-8873","authenticated-orcid":false,"given":"Thomas J","family":"Giordano","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan , Ann Arbor, MI 48106 ,","place":["United States"]},{"name":"Department of Pathology, University of Michigan , Ann Arbor, MI \u00a0","place":["48109, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1083-1575","authenticated-orcid":false,"given":"Megan R","family":"Haymart","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan , Ann Arbor, MI 48106 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1438-3220","authenticated-orcid":false,"given":"Rajesh V","family":"Thakker","sequence":"additional","affiliation":[{"name":"Academic Endocrine Unit, University of Oxford , Oxford, OX3 7LJ ,","place":["United Kingdom"]},{"name":"National Institute for Health Research Oxford Biomedical Research Centre , Oxford, OX3 9DU ,","place":["United Kingdom"]},{"name":"Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London , London, EC1M 6BQ ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3755-7529","authenticated-orcid":false,"given":"Gregory A","family":"Clines","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan , Ann Arbor, MI 48106 ,","place":["United States"]},{"name":"Ann Arbor Veterans Affairs Healthcare System , Ann Arbor, MI 48105 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"issue":"6","key":"2026082903272102700_ref1","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1210\/clinem\/dgaa113","article-title":"Hypoparathyroidism","volume":"105","author":"Bilezikian","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"15","key":"2026082903272102700_ref2","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1056\/NEJM199610103351505","article-title":"A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor","volume":"335","author":"Pearce","year":"1996","journal-title":"N Engl J Med"},{"issue":"26","key":"2026082903272102700_ref3","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1056\/NEJMc1300278","article-title":"Germline mutations affecting G\u03b111 in hypoparathyroidism","volume":"368","author":"Mannstadt","year":"2013","journal-title":"N Engl J Med"},{"issue":"6","key":"2026082903272102700_ref4","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1210\/jc.2015-3908","article-title":"Epidemiology and diagnosis of hypoparathyroidism","volume":"101","author":"Clarke","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2026082903272102700_ref5","doi-asserted-by":"publisher","first-page":"E1774","DOI":"10.1210\/jc.2014-1029","article-title":"Autosomal dominant hypoparathyroidism caused by germline mutation in GNA11: phenotypic and molecular characterization","volume":"99","author":"Li","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026082903272102700_ref6","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S2213-8587(13)70106-2","article-title":"Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study","volume":"1","author":"Mannstadt","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"2026082903272102700_ref7","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1210\/jc.2011-1908","article-title":"Synthetic human parathyroid hormone 1-34 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism","volume":"97","author":"Winer","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026082903272102700_ref8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1056\/NEJMc2034981","article-title":"PTH infusion ameliorates seizures in autosomal dominant hypocalcemia type 1","volume":"385","author":"Sastre","year":"2021","journal-title":"N Engl J Med"},{"issue":"1","key":"2026082903272102700_ref9","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/jbmr.4726","article-title":"Efficacy and safety of parathyroid hormone replacement with TransCon PTH in hypoparathyroidism: 26-week results from the phase 3 PaTHway trial","volume":"38","author":"Khan","year":"2023","journal-title":"J Bone Miner Res"},{"issue":"13","key":"2026082903272102700_ref10","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1056\/NEJMc2302708","article-title":"Efficacy and safety of encaleret in autosomal dominant hypocalcemia type 1","volume":"389","author":"Gafni","year":"2023","journal-title":"N Engl J Med"},{"issue":"3","key":"2026082903272102700_ref11","doi-asserted-by":"publisher","first-page":"e91079","DOI":"10.1172\/jci.insight.91079","article-title":"Knockin mouse with mutant G\u03b111 mimics human inherited hypocalcemia and is rescued by pharmacologic inhibitors","volume":"2","author":"Roszko","year":"2017","journal-title":"JCI Insight"},{"issue":"4","key":"2026082903272102700_ref12","doi-asserted-by":"publisher","first-page":"R203","DOI":"10.1530\/JME-16-0221","article-title":"Heterotrimeric G proteins in the control of parathyroid hormone actions","volume":"58","author":"Bastepe","year":"2017","journal-title":"J Mol Endocrinol"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jbmr\/advance-article-pdf\/doi\/10.1093\/jbmr\/zjag043\/67153701\/zjag043.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/41\/9\/934\/67153701\/zjag043.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/41\/9\/934\/67153701\/zjag043.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T07:27:30Z","timestamp":1787988450000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/41\/9\/934\/8500972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":12,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,2,27]]},"published-print":{"date-parts":[[2026,8,21]]}},"URL":"https:\/\/doi.org\/10.1093\/jbmr\/zjag043","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,2,27]]}}}